Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OPRM1 | P35372 | 4/20 | 0.42 |
| ▸ | DRD4 | P21917 | 11/20 | 0.41 |
| ▸ | DRD2 | P14416 | 6/20 | 0.41 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.40 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.40 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.40 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.40 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.40 |
| ▸ | DRD3 | P35462 | 3/20 | 0.39 |
| ▸ | USP30 | Q70CQ3 | 1/20 | 0.39 |
| ▸ | ADRA1D | P25100 | 1/20 | 0.39 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.39 |
| ▸ | ADRA1B | P35368 | 1/20 | 0.39 |
| ▸ | KDM5A | P29375 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6965093 | 0.80 | OPRM1 (0.42) | OPRM1DRD4DRD2CHRM2CHRM4 | |
| SCHEMBL16218248 | 0.80 | CHRM2 (0.47) | OPRM1DRD4DRD2CHRM2CHRM4 | |
| SCHEMBL6962969 | 0.76 | DRD4 (0.46) | DRD4DRD2CHRM2CHRM4CHRM5 | |
| SCHEMBL2737376 | 0.75 | KDM5A (0.48) | OPRM1DRD4CHRM2CHRM4CHRM5 | |
| SCHEMBL31754475 | 0.74 | USP30 (0.57) | DRD4CHRM2CHRM4CHRM5CHRM1 | |
| SCHEMBL7842113 | 0.74 | DRD4 (0.43) | OPRM1DRD4DRD2CHRM2CHRM4 | |
| SCHEMBL7225193 | 0.74 | DRD4 (0.43) | OPRM1DRD4DRD2CHRM2CHRM4 | |
| SCHEMBL171599 | 0.72 | DRD4 (0.48) | DRD4DRD2CHRM2CHRM4CHRM5 | |
| SCHEMBL29352448 | 0.72 | DRD4 (0.48) | DRD4DRD2CHRM2CHRM4CHRM5 | |
| SCHEMBL19652164 | 0.71 | KDM5A (0.54) | DRD4DRD2DRD3USP30ADRA1D |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6620815-B1 | Selective antagonists for human alpha 1A receptors; benign prostatic hyperplasia, impotency, cardiac arrhythmia treatment; anticholesterol agents; intraocular pressure reduction | SYNAPTIC PHARMACEUTICAL CORPORATION | 2003-09-16 | — | — | US | disclosed |
| EP-0988295-A4 | HETEROCYCLIC SUBSTITUTED PIPERIDINES AND USES THEREOF | SYNAPTIC PHARMA CORP (US) | 2003-08-13 | — | — | EP | disclosed |
| US-6159990-A | Oxazolidinones as α1A receptor antagonists | SYNAPTIC PHARMACEUTICAL CORPORATION (US) | 2000-12-12 | — | — | US | disclosed |
| EP-0988295-A1 | HETEROCYCLIC SUBSTITUTED PIPERIDINES AND USES THEREOF | SYNAPTIC PHARMACEUTICAL CORPORATION (US) | 2000-03-29 | — | — | EP | disclosed |
| WO-1998057940-A1 | HETEROCYCLIC SUBSTITUTED PIPERIDINES AND USES THEREOF | SYNAPTIC PHARMACEUTICAL CORPORATION (US) | 1998-12-23 | — | — | WO | disclosed |